MetaVia Inc. — Director's Dealing 2016

Aug 8, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2016-08-04

Reporting Person: Bisgaier Charles PhD (Director, Chief Scien. Officer & Chair, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-04	Employee Stock Option (right to buy)	$10	A	150000	Acquired	2026-08-03	Common Stock (150000)	Direct

Footnotes

F1: The option vests in 48 equal consecutive monthly increments, so that all of the shares will be vested on the fourth anniversary of the date of grant.